Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning.
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsStriatal glutamate release in L-DOPA-induced dyskinetic animalsBrain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Genetically modified pig models for neurodegenerative disorders.Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's diseaseSerotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs.The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release.Molecular imaging and its applications: visualization beyond imagination.Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
P2860
Q21129423-E5AD12C6-572A-481B-A409-085B40BAC771Q28485942-B31C0A54-771D-4602-9066-BA321856C135Q30833645-D5ADB0AD-4F4B-4153-A894-3BF52843FE96Q31002975-66E51A7C-B498-4E9B-A87F-130EBCA0C5B9Q35116470-07B3D3A3-C532-4D61-9853-5CAEB23BE03BQ37602233-46CA78B9-D258-4E8D-9BFE-488D88569E69Q38199670-E1AF4238-FDBA-4C4D-A574-F4C6A7DCC79CQ38218100-6BAB7C74-0533-4870-A46F-C3B960E39613Q38262418-3C80C9CF-60B9-4878-BF3F-3E736AFF7A9CQ38532562-3CF42DB4-973E-4EF4-826D-F4934B057167Q40379397-A53056AE-A416-4472-AA26-339979A6E434Q42640556-5CD9C791-2A78-434F-B128-21E44432C948Q46782965-2287A78D-4A3F-45EF-BB6E-6105F2898699Q53410082-C9E060C5-4F98-4AD9-99DD-7A4E9465EA4C
P2860
Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@en
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@nl
type
label
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@en
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@nl
prefLabel
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@en
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@nl
P2093
P2860
P1476
Serotonergic modulation of rec ...... r unilateral 6-OHDA lesioning.
@en
P2093
Aage Kristian Olsen Alstrup
Adjmal Nahimi
Anne M Landau
Arne Møller
Doris J Doudet
Mette Høltzermann
Mette Simonsen
Steen Jakobsen
P2860
P304
P356
10.1111/J.1471-4159.2011.07598.X
P407
P577
2012-01-23T00:00:00Z